DDB2 and breast carcinoma: Elevated expression of DDB2 has been linked to enhanced DNA repair capacity and poor clinical responses to DNA alkylating or interstrand cross-link agents in melanoma 11, glioblastoma 12, lung 13, and breast cancers 14.